跳至主要内容
临床试验/TCTR20220516003
TCTR20220516003招募中4 期

Test and Treat HIV and Viral Hepatitis for Most at Risk Populations in Central and Southeast Asia: The C-FREE-CSEA Study

Dreamlopments Foundation0 个研究点目标入组 4,800 人开始时间: 2022年5月16日最近更新:
适应症

试验速览

阶段
4 期
状态
招募中
发起方
入组人数
4,800

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 Years 至 N/A (No limit)(—)
性别
All

入选标准

  • Male, female, or transgender person.
  • Aged 18 years old or older.
  • Former or active injecting or non-injecting drug user. PWID/PWUD are expected to represent the largest sub-population of participants enrolling in the study.
  • Men-who-have-se-with-men (MSM).
  • Sexual or life partner of a current or former drug user, or other high-risk group (MSM, TG women).
  • Consenting to participate in the study.
  • Willing to undertake at least HIV Ab testing and/or HCV Ab testing. Candidates with evidence (written medical/laboratory report) of prior testing (including positive testing) for HIV, HCV, HBV, STI, or LTBI infection can also enroll into the cohort study.
  • Consenting to participant in the study

排除标准

  • Inability, in the opinion of the study staff, to provide an informed consent decision to participate in the study.

研究者

发起方
Dreamlopments Foundation

相似试验